ArticleFrontiers in immunology2024
Commentary: Phosducin-like 3 is a novel prognostic and onco-immunological biomarker in glioma: a multi-omics analysis with experimental verification.
Jihao Xue et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.